Interim report for the third quarter 2020, January 1st – September 30th, 2020

by | Nov 20, 2020

Third quarter in brief as well as the period 1 January – 30 September 2020Net sales for the period (January to September) amounted to SEK 0,09 million (3,3 million), of which the third quarter contributed SEK 0,05 million (0,20 million).R&D costs for the period...

Delårsrapport för tredje kvartalet 2020, 1 januari – 30 september 2020

by | Nov 20, 2020

Tredje kvartalet i korthet samt perioden 1 januari – 30 september 2020Nettoomsättningen för perioden (januari till september) uppgick till 0,09 Mkr (3,3 Mkr), varav tredje kvartalet utgjorde 0,05 Mkr (0,20 Mkr).FoU-kostnader för perioden uppgick till 28,1 Mkr (27,5...

Interim report for the second quarter 2020. January 1st – June 30th, 2020

by kancerawebedit | Aug 21, 2020

Second quarter in brief and the period 1 January – 30 June 2020   Net sales for the period (January to June) amounted to SEK 2,6 million (3,1 million), of which the second quarter contributed SEK 2,6 million (0). R&D costs for the period amounted to SEK 19,3...

Delårsrapport för andra kvartalet 2020, 1 januari – 30 juni 2020

by kancerawebedit | Aug 21, 2020

Andra kvartalet i korthet samt perioden 1 januari – 30 juni 2020 Nettoomsättning för perioden (januari till juni) uppgick till 2,6 Mkr (3,1 Mkr), varav andra kvartalet utgjorde 2,6 Mkr (0 Mkr). FoU-kostnader för perioden uppgick till 19,3 Mkr (20,3 Mkr), varav andra...

Interim report for the first quarter 2020, 1 januari-31 March 2020 Kancera AB (publ.), org.nr. 556806-8851.

by kancerawebedit | Jun 10, 2020

First quarter in brief 1 January – 31 March 2020 Net sales for the period (January to March) amounted to SEK 0,04 million (3,1). R&D costs for the period amounted to SEK 9,7 million (10,2). Operating profit for the period amounted to SEK -11,1 million (-7,9)....